Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX)
Sector: Medical
Current Price :
$7.88
52 Week Low
$1.28
52 Week High
$9.08
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
81M
Market Cap:
$0.66B
Avg Volume:
2245392
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
A Down Day For The Indices
Jan 30, 2013 10:57 PM |
AAPL
,
AMZN
,
AVY
,
BTU
,
GMCR
,
ISIS
Mixed, Productive Day
Jan 29, 2013 07:25 PM |
AAPL
,
AMZN
,
BTU
,
DK
,
FSLR
,
GMCR
A Sloppy, Choppy Session And Mixed Close
Jan 28, 2013 07:26 PM |
AAPL
,
ACAD
,
AMZN
,
ARUN
,
CREE
,
CVR
More Articles on KERX..
Press Releases
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
May 07, 2013 04:30 PM |
KERX
Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results
May 06, 2013 04:30 PM |
KERX
Morning Research on Sanofi, Keryx Biopharma, VIVUS, and Array BioPharma
Mar 27, 2013 08:00 AM |
ARRY
,
KERX
,
SNY
,
VVUS
More Press Releases on KERX..
SEC Filings
Form 4 KERYX BIOPHARMACEUTICALS For: Jun 27 Filed by: Kaye Jack (10K)
Feb 15, 2013 07:43 PM
Form 4 KERYX BIOPHARMACEUTICALS For: Oct 03 Filed by: BENTSUR RON (10K)
Oct 05, 2012 07:18 PM
Form 4 KERYX BIOPHARMACEUTICALS For: Jul 03 Filed by: Oliviero James F III (10K)
Jul 06, 2012 07:10 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
KERX
Compare to S&P
YTD
206.49 %
181.05 %
4 Weeks
13.58 %
13.70 %
12 Weeks
134.11 %
126.24 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-12.50 %
EPS Growth in Last Year:
25.00 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##